Education
About Us
Working with TipRanks
Follow Us
Bionovate Technologies (BIIO)
OTHER OTC:BIIO
Total Valuation
Bionovate Technologies has a market cap or net worth of $8.00. The enterprise value is $238.16K.
Market Cap$8.00
Enterprise Value$238.16K
Share Statistics
Bionovate Technologies has 7,753,598 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,753,598
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bionovate Technologies’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 17.07%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)17.07%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bionovate Technologies is ―. Bionovate Technologies’s PEG ratio is <0.00001.
PE Ratio―
PS Ratio0.00
PB Ratio>-0.01
Price to Fair Value>-0.01
Price to FCF-0.03
Price to Operating Cash Flow-3.29
PEG Ratio<0.00001
Income Statement
In the last 12 months, Bionovate Technologies had revenue of 0.00 and earned -106.54K in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit0.00
Operating Income-45.37K
Pretax Income-106.54K
Net Income-106.54K
EBITDA-45.37K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -236.00 and capital expenditures 0.00, giving a free cash flow of -236.00 billion.
Operating Cash Flow-236.00
Free Cash Flow-236.00
Free Cash Flow per Share>-0.01
Dividends & Yields
Bionovate Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta173.41
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Bionovate Technologies upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Bionovate Technologies as a current ratio of 0.00, with Debt / Equity ratio of -47.17%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap32.23K
Net Debt to EBITDA-5.23
Interest Coverage Ratio-0.74
Taxes
In the past 12 months, Bionovate Technologies has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Bionovate Technologies EV to EBITDA ratio is -5.23, with an EV/FCF ratio of -1.01K.
EV to Sales0.00
EV to EBITDA-5.23
EV to Free Cash Flow-1.01K
EV to Operating Cash Flow-1.01K
Balance Sheet
Bionovate Technologies has $0.00 in cash and marketable securities with $237.53K in debt, giving a net cash position of -$237.53K billion.
Cash & Marketable Securities$0.00
Total Debt$237.53K
Net Cash-$237.53K
Net Cash Per Share-$0.03
Tangible Book Value Per Share-$0.06
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Bionovate Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―